← Back to Clinical Trials
Recruiting NCT06875479

NCT06875479 Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06875479
Status Recruiting
Phase
Sponsor Shanghai 6th People's Hospital
Condition Obstructive Sleep Apnea (OSA)
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2025-04-20
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL
Interventions
Five Seasons [5S] Sleep Tracking Mat

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2025-04-20 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate and compare the diagnostic accuracy and effectiveness of the Five Seasons Sleep Tracking Mat with the gold standard, polysomnography.

Eligibility Criteria

Inclusion Criteria: * Participants between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA. * Participants who are willing to undergo overnight PSG. Exclusion Criteria: * Participants with presence of severe cardiovascular or cerebrovascular diseases, or significant impairment of liver, kidney, or lung function. * Participants with concurrent unstable respiratory diseases or other acute-phase respiratory illnesses. * Participants using, at long term or currently, barbiturates, benzodiazepines, sedatives, or other medications that may affect sleep. * Participants undergoing continuous positive airway pressure (CPAP) therapy or other sleep-related treatments on the study night. * Participants coexisting insomnia, parasomnia, or other sleep disorders. * Participants with psychiatric disorders. * Participants refusing to sign the informed consent form. * Participants unable to cooperate with the required examinations. * Participants with any other conditions deemed unsuitable for inclusion by the investigators.

Contact & Investigator

Central Contact

Weijun Huang, Dr.

✉ hellohuangwj@126.com

📞 86 18930174480

Frequently Asked Questions

Who can join the NCT06875479 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Obstructive Sleep Apnea (OSA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06875479 currently recruiting?

Yes, NCT06875479 is actively recruiting participants. Contact the research team at hellohuangwj@126.com for enrollment information.

Where is the NCT06875479 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06875479 clinical trial?

NCT06875479 is sponsored by Shanghai 6th People's Hospital. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology